A Regenerative Approach to Fibromyalgia
Fibromyalgia steals your life one symptom at a time.
Widespread pain making every movement agonizing. Crushing fatigue that sleep cannot fix. Brain fog destroying concentration and memory. Depression and anxiety from years of suffering that doctors cannot explain or effectively treat. Conventional medicine offers pain medications that barely help, antidepressants with intolerable side effects, and sleep aids creating dependence without addressing the disease destroying your quality of life.
At RejuvStem in Cancun, Mexico, we provide a regenerative approach: pharmaceutical-grade Dezawa MuseCells® therapy targeting the neuroinflammatory and immune dysfunction underlying fibromyalgia itself. As an authorized partner of MuseCell Innovations® in Mexico, our COFEPRIS-certified Cancun facility delivers advanced regenerative protocols using allogeneic Dezawa MuseCells® with documented capacity to modulate immune responses, reduce neuroinflammation, support mitochondrial function, and address the biological mechanisms driving fibromyalgia symptoms.
Unlike autologous stem cell procedures using patients’ own compromised cells, our Dezawa MuseCells® therapy employs young, healthy donor-derived cells with superior immunomodulatory and regenerative potential proven in over 85 peer-reviewed studies. For patients suffering from fibromyalgia in Cancun, this represents access to cutting-edge regenerative medicine targeting disease mechanisms rather than merely masking symptoms.
Call RejuvStem Cancun+1 (302) 551 3530to discuss pharmaceutical-grade Dezawa MuseCells® therapy for your fibromyalgia before further neurological damage occurs.→Understanding Fibromyalgia: Beyond “It’s All in Your Head”
The National Institute of Arthritis and Musculoskeletal and Skin Diseases recognizes fibromyalgia as a chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, cognitive dysfunction, and multiple associated symptoms affecting approximately 4 million American adults. For decades dismissed as psychosomatic, fibromyalgia is now understood as a neurobiological disorder involving central nervous system sensitization, immune dysfunction, and metabolic abnormalities.
Research published in Nature Reviews Rheumatology reveals that fibromyalgia involves central sensitization—abnormal pain processing in the brain and spinal cord making patients hypersensitive to stimuli that wouldn’t cause pain in healthy individuals. Neuroimaging studies demonstrate altered brain activity patterns, neurotransmitter imbalances, and inflammatory markers confirming fibromyalgia’s biological reality.
The Neuroinflammation Connection
Studies published in the Journal of Neuroinflammation demonstrate that fibromyalgia patients exhibit elevated inflammatory markers in cerebrospinal fluid, activated microglia in brain imaging, and pro-inflammatory cytokine profiles driving symptom severity. This neuroinflammation sensitizes pain pathways, disrupts sleep architecture, and contributes to cognitive dysfunction characterizing fibromyalgia.
Research in the Proceedings of the National Academy of Sciences confirms that inflammatory mediators including IL-6, IL-8, and TNF-α correlate directly with fibromyalgia pain intensity and fatigue severity. This inflammatory component explains why anti-inflammatory interventions—when effective enough—can reduce fibromyalgia symptoms.
Immune Dysfunction and Autoimmune Features
Emerging research published in Journal of Autoimmunity identifies autoimmune characteristics in many fibromyalgia patients including:
- •Elevated levels of autoantibodies against nervous system proteins
- •Dysregulated T-cell and B-cell populations
- •Abnormal natural killer (NK) cell function
- •Inflammatory cytokine profiles resembling autoimmune diseases
This immune dysfunction suggests fibromyalgia represents, at least partially, an autoimmune or autoinflammatory process. At our Cancun facility, Dezawa MuseCells® therapy targets this immune dysregulation conventional treatments cannot adequately modulate.
Mitochondrial Dysfunction and Energy Deficits
The crushing fatigue and exercise intolerance fibromyalgia patients experience reflects genuine metabolic dysfunction. Studies in Arthritis Research & Therapy demonstrate that fibromyalgia patients exhibit:
- •Reduced mitochondrial ATP production
- •Elevated oxidative stress markers
- •Impaired cellular energy metabolism
- •Abnormal lactate accumulation during minimal exertion
This mitochondrial dysfunction explains why fibromyalgia fatigue differs from normal tiredness—cellular energy production is genuinely impaired. Dezawa MuseCells® therapy in Cancun addresses this metabolic component through mechanisms supporting mitochondrial health.
How Dezawa MuseCells® Address Fibromyalgia’s Complex Pathology
Dezawa MuseCells® offer unique advantages for fibromyalgia treatment according to extensive research compiled by MuseCell Innovations®. Unlike standard treatments targeting individual symptoms, Dezawa MuseCells® address multiple fibromyalgia mechanisms simultaneously:
- •IL-10 and TGF-β suppressing pro-inflammatory immune responses
- •Regulatory T-cell (Treg) induction promoting immune tolerance
- •Modulation of macrophage and microglial activation reducing neuroinflammation
- •Suppression of autoantibody production when autoimmune features exist
- •Reduce microglial activation in the brain and spinal cord
- •Suppress inflammatory cytokine production in central nervous system tissues
- •Support neuronal survival in inflammatory environments
- •Promote anti-inflammatory M2 macrophage/microglia phenotypes
- •Support neuronal health and survival
- •Promote beneficial neuroplasticity reversing maladaptive pain processing
- •Enhance neurotransmitter balance including serotonin and norepinephrine
- •Protect against stress-induced neuronal damage
- •Secreting growth factors that enhance mitochondrial biogenesis
- •Reducing oxidative stress damaging mitochondrial function
- •Supporting cellular energy metabolism through paracrine signaling
- •Promoting metabolic flexibility improving energy utilization
Clinical Evidence Supporting Stem Cell Therapy for Fibromyalgia
While fibromyalgia research lags behind osteoarthritis and other conditions, emerging evidence supports regenerative approaches for this complex disorder.
- •Significant reduction in pro-inflammatory cytokine levels
- •Increased anti-inflammatory and regulatory immune cell populations
- •Suppression of autoimmune responses when present
- •Improved immune tolerance reducing inappropriate inflammation
- •Neuropathic pain models show significant pain reduction following stem cell administration
- •Central sensitization improves as neuroinflammation resolves
- •Pain processing normalization documented through functional brain imaging
- •Long-term pain relief maintained beyond acute anti-inflammatory effects
- •Significant energy level improvements
- •Enhanced physical function and exercise tolerance
- •Better sleep quality and restorative sleep
- •Improved cognitive function and reduced brain fog
- •Enhanced quality of life across multiple domains
Research published in Stem Cells Translational Medicine demonstrates that stem cell therapy modulates immune function in chronic inflammatory and autoimmune conditions through mechanisms directly relevant to fibromyalgia pathophysiology. While specific fibromyalgia trials are limited, extensive research published in Pain and The Journal of Pain demonstrates stem cell therapy’s efficacy for chronic pain conditions sharing fibromyalgia’s mechanisms. These findings suggest Dezawa MuseCells® therapy in Cancun may benefit fibromyalgia patients through similar pain modulation mechanisms.
Studies examining stem cell therapy for chronic fatigue syndrome and autoimmune conditions published in Fatigue: Biomedicine, Health & Behavior document the fatigue and quality-of-life improvements above. For fibromyalgia patients in Cancun seeking comprehensive symptom improvement, these multi-domain benefits prove particularly valuable.
Why Cancun for Fibromyalgia Treatment: The RejuvStem Advantage
- •Genuine Dezawa MuseCells® produced under Professor Mari Dezawa’s patented methods
- •Certificate of Analysis documenting pharmaceutical-grade quality testing
- •SSEA-3 marker verification confirming authentic MUSE cell identity
- •Protection against fraudulent clinics making false “MUSE cell” claims without authorization
- •Rigorous donor screening excluding infectious disease and genetic disorders
- •Pharmaceutical-grade laboratory processing under sterile GMP conditions
- •Comprehensive quality control testing confirming cell viability, potency, and sterility
- •Complete documentation from donor screening through patient administration
- •Chronic disease and inflammation reduce autologous stem cell quality
- •Fibromyalgia patients’ own cells show reduced immunomodulatory capacity
- •Medications commonly used for fibromyalgia impair stem cell function
- •Stress and sleep deprivation characteristic of fibromyalgia compromise cellular health
Comprehensive Fibromyalgia Treatment Protocol in Cancun
- •Complete symptom inventory documenting pain locations, severity, and patterns
- •Fatigue assessment and sleep quality evaluation
- •Cognitive function and mood symptom review
- •Current medication list including pain medications, antidepressants, and sleep aids
- •Previous treatment history documenting what has and hasn’t helped
Pharmaceutical-grade cell preparation: Dezawa MuseCells® undergo final quality verification and preparation for administration.
Optimized delivery: Based on symptom patterns and severity, our Cancun team administers Dezawa MuseCells® via:
- Intravenous infusion: Primary delivery method for fibromyalgia providing systemic immunomodulatory effects, neuroinflammation reduction, and multi-organ benefits
- Targeted injections: Some patients receive additional localized injections into particularly painful trigger points or areas of severe muscle tension
- Combined protocols: Integration with complementary therapies maximizing regenerative response
Nutritional optimization: Mitochondrial support requires specific nutrients including CoQ10, B-vitamins, magnesium, and omega-3 fatty acids. Our Cancun team provides targeted supplementation.
Sleep hygiene guidance: Quality sleep is essential for healing. We provide evidence-based sleep optimization strategies.Most fibromyalgia patients complete treatment in Cancun within 2-4 days.
Expected Outcomes: Realistic Timeline for Fibromyalgia Improvement
- •Gradual reduction in overall pain intensity
- •Slight improvements in energy levels and fatigue
- •Better sleep quality as inflammation decreases
- •Reduced need for pain medications
- •Pain intensity continues declining as neuroinflammation resolves
- •Energy levels improve more substantially as mitochondrial function enhances
- •Cognitive function sharpens as brain inflammation reduces
- •Mood improves alongside symptom relief
- •Exercise tolerance increases allowing gradual activity expansion
- •Symptoms stabilize at substantially improved baseline
- •Many patients reduce or eliminate fibromyalgia medications
- •Quality of life metrics show dramatic improvement
- •Return to activities abandoned due to fibromyalgia becomes possible
- •Many patients maintain improvements for 1-3+ years following single treatments
- •Some benefit from periodic re-treatment in Cancun for sustained symptom control
- •Lifestyle optimization including stress management, sleep hygiene, and gentle exercise supports lasting benefits
Early improvements relate to Dezawa MuseCells®’ immunomodulatory and anti-inflammatory effects—these early changes reflect the beginning of immune system rebalancing. Most fibromyalgia patients reach peak improvement within 6-12 months. Fibromyalgia is a chronic condition requiring ongoing management.
Call RejuvStem Cancun+1 (302) 551 3530to discuss expected outcomes for your fibromyalgia.→Who Benefits Most from Dezawa MuseCells® Therapy in Cancun
Ideal Candidates
- •Moderate to severe fibromyalgia: Patients with significant symptom burden affecting daily function despite conventional treatment.
- •Failed medication trials: Those who have tried multiple fibromyalgia medications (gabapentin, duloxetine, pregabalin, amitriptyline) without adequate relief or with intolerable side effects.
- •Motivated patients: Individuals committed to comprehensive healing including lifestyle modifications supporting regenerative response.
- •Autoimmune features: Fibromyalgia patients with documented autoimmune markers may particularly benefit from Dezawa MuseCells®’ immunomodulatory effects.
Important Considerations
Fibromyalgia treatment requires realistic expectations. Dezawa MuseCells® therapy in Cancun:
- •Does not provide instant symptom resolution—healing requires weeks to months
- •Works best alongside comprehensive lifestyle management
- •May not eliminate all symptoms but can substantially reduce severity
- •Represents part of ongoing fibromyalgia management rather than a permanent cure
Our Cancun team provides honest assessments of expected outcomes.
Frequently Asked Questions About Fibromyalgia Treatment in Cancun
Medications like gabapentin and duloxetine modulate neurotransmitters but don’t address immune dysfunction or neuroinflammation. Dezawa MuseCells® target underlying disease mechanisms potentially providing more comprehensive and lasting improvement.
Many patients reduce or eliminate medications following successful Dezawa MuseCells® therapy in Cancun. Medication changes should be made gradually under physician supervision.
Most fibromyalgia patients complete treatment within 2-4 days including evaluation, Dezawa MuseCells® administration, and post-treatment monitoring.
Fibromyalgia and CFS share pathophysiological mechanisms. Dezawa MuseCells®’ immunomodulatory and mitochondrial support effects may benefit both conditions.
End Your Fibromyalgia Suffering: Begin Healing in Cancun
Fibromyalgia doesn’t have to control your life. Pharmaceutical-grade Dezawa MuseCells® therapy at RejuvStem in Cancun offers genuine regenerative potential addressing immune dysfunction, neuroinflammation, and metabolic abnormalities that medications cannot adequately treat.
Advanced regenerative medicine. Pharmaceutical-grade standards. Hope for fibromyalgia. Accessible in Cancun.
As an authorized partner of MuseCell Innovations® in Mexico, our COFEPRIS-certified Cancun facility delivers advanced regenerative medicine using allogeneic Dezawa MuseCells® backed by over 85 peer-reviewed studies.
- •Complete fibromyalgia symptom review
- •Honest assessment of Dezawa MuseCells® therapy appropriateness
- •Expected improvement timeline discussion
- •Transparent pricing
- •Travel planning assistance
Advanced regenerative medicine. Pharmaceutical-grade standards. Hope for fibromyalgia. Accessible in Cancun.
- 1NIAMS – Fibromyalgia
- 2Nature Reviews Rheumatology
- 3Journal of Neuroinflammation
- 4PNAS
- 5Journal of Autoimmunity
- 6Arthritis Research & Therapy
- 7MuseCell Innovations®
- 8The Journal of Immunology
- 9Nature Neuroscience
- 10Molecular Psychiatry
- 11Cell Metabolism
- 12Stem Cells Translational Medicine
- 13Pain
- 14The Journal of Pain
- 15Fatigue: Biomedicine, Health & Behavior
- 16National Institute on Aging
Medical Disclaimer: Dezawa MuseCells® therapy is performed in Mexico under COFEPRIS regulation. Not FDA-approved in the United States. Individual results vary.
